Serotiny
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(415) 742-1139Website
serotiny.bioRevenue
<$5 MillionIndustry
About Serotiny
Serotiny Org Chart
Is Serotiny your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Serotiny has recently received funding, and reach out quickly before it becomes old news!
Check out if Serotiny is spiking on competitors!
Funding: Get notified immidiatlly once Serotiny has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Serotiny
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Serotiny had a recent Job posting/layoffs
Earning: See what the market has to say on Serotiny recently announced quarterly report
Serotiny, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Serotiny launches new products
Recommended Actions
Find VP level buyers at Serotiny
Find more new buyers
Compare Similar Companies to Serotiny
Compare insights from companies similar to Serotiny, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Serotiny is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Serotiny is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Serotiny.
Serotiny Tech Stack
A closer look at the technologies used by Serotiny
Serotiny News & Media
Serotiny Appoints Chad May, Ph.D., as Chief Scientific Officer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Serotiny, a leader in high-throughput therapeutic Multi-Domain Protein (tMDP) engineering for the next generation of cell and gene therapies, has appointed Chad May, Ph.D., as the company's Chief Scientific Officer. In this new role, Dr. May will lead the research and development of Serotiny’s novel therapeutics programs. "Chad is a fantastic addition to the Serotiny leadership team," said Serotiny Chief Executive Officer Colin Farlow. "His deep expSerotiny and Tessera Therapeutics enter into collaboration to engineer and optimize programmable Gene Writer proteins
SAN FRANCISCO--(BUSINESS WIRE)--Serotiny, a leader in high-throughput therapeutic Multi-Domain Protein (tMDP) engineering, and Tessera Therapeutics, a biotechnology company pioneering a new approach in genetic medicines known as Gene Writing technology, today announced a collaboration to engineer programmable Gene Writer proteins. This collaboration will build on Tessera’s innovations in genome engineering technologies and apply Serotiny’s tMDP mining and design expertise to further optimize Te
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Serotiny
Serotiny is a pre-clinical discovery company building better gene and cell therapies through engineering Therapeutic Multi-Domain Proteins (tMDP) such as Chimeric Antigen Receptors (CARs), alternative CARs, accessory proteins and gene editing systems in high-throughput. At the heart of Serotiny's technology is a discovery platform that harmonizes c... Read More